Evolutionary Genomics Inc (FNAM)
0.0008
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Evolutionary Genomics Net Income (Quarterly): -0.3338M for Dec. 31, 2022
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.3338M |
| September 30, 2022 | -0.5453M |
| June 30, 2022 | -0.5311M |
| March 31, 2022 | -0.5249M |
| December 31, 2021 | -0.6678M |
| September 30, 2021 | -1.059M |
| June 30, 2021 | -0.5537M |
| March 31, 2021 | -0.5137M |
| December 31, 2020 | -1.711M |
| September 30, 2020 | 0.5359M |
| June 30, 2020 | -0.2948M |
| March 31, 2020 | -0.2418M |
| December 31, 2019 | -0.2547M |
| September 30, 2019 | -0.1563M |
| June 30, 2019 | -0.1817M |
| March 31, 2019 | -0.2004M |
| December 31, 2018 | -0.1852M |
| September 30, 2018 | -0.2653M |
| June 30, 2018 | -0.358M |
| March 31, 2018 | -0.2901M |
| December 31, 2017 | 0.5163M |
| September 30, 2017 | -0.2532M |
| June 30, 2017 | -0.2675M |
| March 31, 2017 | -0.5287M |
| December 31, 2016 | -0.2704M |
| Date | Value |
|---|---|
| September 30, 2016 | -0.2711M |
| June 30, 2016 | -0.3195M |
| March 31, 2016 | -0.291M |
| December 31, 2015 | 0.4523M |
| September 30, 2015 | -0.2054M |
| June 30, 2015 | -0.6325M |
| March 31, 2015 | 0.0996M |
| December 31, 2014 | -1.377M |
| September 30, 2014 | -0.0092M |
| June 30, 2014 | -0.0103M |
| March 31, 2014 | -0.0024M |
| December 31, 2013 | -0.0035M |
| September 30, 2013 | -0.0035M |
| June 30, 2013 | -0.0088M |
| March 31, 2013 | -0.0034M |
| December 31, 2012 | -0.0038M |
| September 30, 2012 | -0.0032M |
| June 30, 2012 | -0.0027M |
| March 31, 2012 | -0.0074M |
| December 31, 2011 | -0.0021M |
| September 30, 2011 | -0.0061M |
| June 30, 2011 | -0.0019M |
| March 31, 2011 | -0.0072M |
| December 31, 2010 | -0.0117M |
| September 30, 2010 | -0.0086M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.711M
Minimum
Dec 2020
0.5359M
Maximum
Sep 2020
-0.515M
Average
-0.5249M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | -2.054M |
| FluoroPharma Medical Inc | -0.1272M |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | -0.4328M |
| Regenerx Biopharmaceuticals Inc | -0.3852M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.4122M |
| EPS Diluted (Quarterly) | -0.06 |